3.2.1.114	0.000005	-	swainsonine	in 50 mM sodium acetate buffer pH 5.8, at 37°C	714909	
3.2.1.114	0.00001	-	Mannostatin A	very potent inhibitor, competitive, IC50: about 10 nM with 4-nitrophenyl alpha-D-mannoside as substrate, about 90 nM with GlcNAc(Man)5GlcNAc as substrate, equally potent as swainsonine	646629	
3.2.1.114	0.00001	-	swainsonine	alpha-mannosidase III, IC50: 10 nM	646644	
3.2.1.114	0.00001	-	swainsonine	extracted from endothelial cells HCEC	696732	
3.2.1.114	0.000017	-	swainsonine	-	682766	
3.2.1.114	0.00002	-	swainsonine	extracted from human glioblastoma cells LNZ308	696732	
3.2.1.114	0.000029	-	1-(4-methylphenyl)-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone	pH 5.75, 25°C	708117	
3.2.1.114	0.000029	-	1-(4-tert-butylphenyl)-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone	pH 5.75, 25°C	708117	
3.2.1.114	0.00003	-	1-phenyl-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone	pH 5.75, 25°C	708117	
3.2.1.114	0.000037	-	swainsonine	pH 5.75, 25°C	708117	
3.2.1.114	0.000044	-	(1S,2R,5S,8R,8aR)-5-[2-(4-tert-butylphenyl)ethyl]octahydroindolizine-1,2,8-triol	pH 5.75, 25°C	708117	
3.2.1.114	0.00005	-	swainsonine	extracted from human glioblastoma cells LN18	696732	
3.2.1.114	0.00009	0.0001	D-mannonolactam amidrazone	equally as effective as mannostatin A, IC50: 90-100 nM	646590	
3.2.1.114	0.00013	-	Mannostatin A	in 50 mM sodium acetate buffer pH 5.8, at 37°C	714909	
3.2.1.114	0.00025	-	(1S,2R,5R,8R,8aR)-5-[2-(4-tert-butylphenyl)ethyl]octahydroindolizine-1,2,8-triol	pH 5.75, 25°C	708117	
3.2.1.114	0.00025	-	1-(4-tert-butylphenyl)-2-[(1S,2R,5S,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone	pH 5.75, 25°C	708117	
3.2.1.114	0.0004	-	D-mannonolactam amidrazone	IC50: 400 nM	646590	
3.2.1.114	0.0005	-	(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one	extracted from endothelial cells HCEC	696732	
3.2.1.114	0.0005	-	(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one	extracted from human glioblastoma cells LNZ308	696732	
3.2.1.114	0.00075	-	(3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxy-1-methylpyrrolidin-2-one	extracted from endothelial cells HCEC	696732	
3.2.1.114	0.002	-	(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one	extracted from human glioblastoma cells LN18	696732	
3.2.1.114	0.0075	-	(3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxy-1-methylpyrrolidin-2-one	extracted from human glioblastoma cells LNZ308	696732	
3.2.1.114	0.014	-	8-epi-lentiginosine	-	682772	
3.2.1.114	0.025	-	(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol	extracted from endothelial cells HCEC	696732	
3.2.1.114	0.05	-	(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol	extracted from human glioblastoma cells LN18	696732	
3.2.1.114	0.05	-	(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol	extracted from human glioblastoma cells LNZ308	696732	
3.2.1.114	0.05	-	(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one	extracted from human glioblastoma cells LNZ308	696732	
3.2.1.114	0.075	-	(2S,3R,4S)-2-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]pyrrolidine-3,4-diol	extracted from endothelial cells HCEC	696732	
3.2.1.114	0.075	-	(2S,3R,4S)-2-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]pyrrolidine-3,4-diol	extracted from human glioblastoma cells LNZ308	696732	
3.2.1.114	0.075	-	(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one	extracted from endothelial cells HCEC	696732	
3.2.1.114	0.075	-	(3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxy-1-methylpyrrolidin-2-one	extracted from human glioblastoma cells LN18	696732	
3.2.1.114	0.075	-	(3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxypyrrolidin-2-one	extracted from endothelial cells HCEC	696732	
3.2.1.114	0.15	-	(3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxypyrrolidin-2-one	extracted from human glioblastoma cells LNZ308	696732	
3.2.1.114	0.2	-	(2S,3R,4S)-2-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]pyrrolidine-3,4-diol	extracted from human glioblastoma cells LN18	696732	
3.2.1.114	0.35	-	(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one	extracted from human glioblastoma cells LN18	696732	
3.2.1.114	0.72	-	(2R,3R,4S)-2-([[(1S)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol	-	682766	
3.2.1.114	0.75	-	(3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxypyrrolidin-2-one	extracted from human glioblastoma cells LN18	696732	
3.2.1.114	0.8	-	(2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol	-	682766	
3.2.1.114	1	-	(2R,3R,4S,5R)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-5-methylpyrrolidine-3,4-diol	-	682766	
3.2.1.114	1.5	-	2-phenylethyl alpha-D-mannopyranosyl sulfone	in 50 mM sodium acetate buffer pH 5.8, at 37°C	714909	
3.2.1.114	2	-	benzyl alpha-D-mannopyranosyl sulfone	in 50 mM sodium acetate buffer pH 5.8, at 37°C	714909	
3.2.1.114	2	-	di-epi-swainsonine	-	682772	
3.2.1.114	2.5	-	(RS)-2-phenylethyl alpha-D-mannopyranosyl sulfoxide	in 50 mM sodium acetate buffer pH 5.8, at 37°C	714909